| abstract |
The application relates to treatment and diagnosis in the treatment of diseases and disorders caused by or related to amyloid or amyloid-like proteins, including amyloidosis, a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease. It relates to methods and compositions for use for purposes. The present application provides novel methods and compositions comprising highly specific and highly effective antibodies that have the ability to specifically recognize and bind to specific epitopes derived from a range of β-amyloid proteins. I will provide a. The antibodies made possible by the teachings of this application are caused by amyloid or amyloid-like proteins, including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation, including secondary amyloidosis and age-related amyloidosis, or It is particularly useful in the treatment of diseases and disorders related to these. Such diseases and disorders include, but are not limited to, neurological disorders such as Alzheimer's disease (AD). |